Urology has always carried a heavy administrative load. The specialty is procedurally intensive, payer-dependent, and subject to one of the more punishing regulatory profiles in medicine. Over the past five years, that load has stopped being manageable.
Medicare's 2026 Fee Schedule Hits Urology Hard
Reimbursement has been cut steadily. According to the American Medical Association, nominal Medicare payments to physicians rose just 7% from 2001 to 2025 while practice operating costs rose 59%, producing a 33% real-terms decline in physician pay. Urology took this harder than most because its revenue runs through procedures, and the Centers for Medicare and Medicaid Services (CMS, the federal agency that administers Medicare and Medicaid payment policy) has targeted those procedures directly.
The Reimbursement Squeeze
Medicare pay versus practice operating costs, 2001–2025
The 2026 fee schedule makes the math concrete. CMS cut facility-based urology payments by approximately 9 to 10%, while office and non-facility payments increased around 5%, per reporting from the Large Urology Group Practice Association and AUA News. This site-of-service differential (the gap in what CMS pays for the same procedure depending on whether it is performed in a hospital facility versus an independent office setting) leaves multi-site groups navigating a widening margin gap depending on where procedures are performed.
High-volume procedures like Transurethral Resection of the Prostate (TURP, a surgical procedure to treat urinary obstruction caused by an enlarged prostate) and laser prostatectomy bear a disproportionate share of that facility-side reduction.
At the same time, the cystoscopy supply pack that anchors in-office procedures is being phased down approximately 67% through 2028, from $113.70 in 2024 to $37.63, correcting a 2023 CMS pricing error on a schedule that is already underway. In 2026 the pack sits at $75.67, already well into that correction. For independent groups, these aren't rounding errors.
Cystoscopy Supply Pack (SA058)
Reimbursement rate phasing down 67% through 2028
Prior Authorization Adds Hours Without Adding Revenue
Prior authorization (PA, the process by which insurers require physicians to obtain approval before delivering certain treatments, procedures, or medications) compounds the problem. According to the American Medical Association, more than 90% of physicians say PA has a negative impact on clinical outcomes, and urology is among the hardest-hit specialties.
Imaging, procedures, and medications all require authorization across a patchwork of inconsistent payer policies. Every hour spent on PA doesn't bill. It just costs.
Private Equity Growth Exposes the Credentialing Gap
Private equity (PE) consolidation brought a different set of problems. As urology groups scale across markets and state lines, the credentialing and enrollment infrastructure needed to support that growth rarely keeps pace. A group acquiring a three-physician practice in a new state doesn't just absorb clinical volume.
It inherits a credentialing backlog, gaps in payer enrollment, and license renewal timelines that no one has been tracking. Providers who can't bill in their new market cost the group money from day one. CareLumi's urology specialty workflow is built for this environment, and growing and PE-backed practices can find more on how CareLumi handles acquisition-driven expansion.
All of this lands on administrative teams that are already stretched. According to Verisys, credentialing and enrollment alone averages three to six months, longer across state lines, and all-in manual costs run $3,000 to $5,000 or more per provider, per Credex Healthcare. Enrollment delays cost providers up to $10,000 per day in lost revenue, according to Veracity EG. For a growing group, that math compounds fast.
The Hidden Cost of Staying Manual
For every provider stuck in enrollment limbo
The Credentialing Market Charges More as You Grow
The industry's answer to this problem has made it worse. The credentialing market runs on a cafeteria model: separate charges for payer enrollment, primary source verification (PSV, the process of confirming directly with issuing bodies that a provider's licenses, certifications, and credentials are valid), CAQH management (CAQH, the Council for Affordable Quality Healthcare, maintains a centralized database used by payers to collect and store provider credentialing data), monitoring, re-credentialing (the periodic process by which providers renew their verified credentials with payers and health systems), and software seats. Costs multiply with every payer added.
The practices under the most administrative pressure (multi-state groups, high-volume specialty practices, and PE-backed platforms scaling through acquisition) are exactly the ones the model punishes most, because their payer counts are highest.
The Industry Charges You More as You Grow
All payers.
Every state.
CareLumi Inverts the Model
CareLumi inverts that model. The Credentials Verification Organization (CVO, a platform or body that manages the full credentialing and compliance lifecycle for healthcare providers) platform automates the full credentialing lifecycle end to end: primary source verification, licensing, privileging (the process by which a healthcare organization formally authorizes a provider to perform specific clinical procedures based on verified training and competency), payer enrollment, and 24/7 monitoring, compliance, and audit support across every state, every payer, and every provider.
Where the industry charges per payer, per event, or per module, CareLumi operates on a single flat annual rate per provider, all payers included. The more payers a provider needs, the more the traditional model costs them. With CareLumi, it doesn't matter.
This is made possible by proprietary solutions built specifically for grade-A compliance in regulated spaces like healthcare, deploying frontier AI while maintaining the highest standards of security and compliance. The result is speed, efficiency, and accuracy that manual or legacy-software workflows can't match, plus the operational intelligence to support expansion rather than constrain it.
For urology groups working through PE integration, multi-state expansion, or enrollment backlogs, that's not a back-office upgrade. It's the thing that makes the rest of the growth work.